文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

rECMOmender:强化学习用于静脉-静脉体外膜氧合管理决策支持

rECMOmender: Reinforcement Learning for Decision Support in Venovenous Extracorporeal Membrane Oxygenation Management.
PubMed 文献 · Crit Care Explor · 2026-02-06
一句话结论在184例静脉-静脉ECMO成人患者中,离线强化学习模型生成的参数调整建议与临床实践模式一致,且更倾向于早期积极撤机调整。

本研究为回顾性研究,使用一家三级医疗中心184例接受静脉-静脉ECMO的成人患者的电子健康记录数据,开发了基于保守Q学习、具有生理学信息奖励结构的强化学习智能体rECMOmender。该模型在五个关键参数(FiO2、呼气末正压、呼吸频率、扫气流速和血流速度)上生成稳定、可解释的建议,其FiO2选择40-50%范围最频繁(模型46.75% vs 临床医生45.65%),倾向于呼气末正压9-11 cm H2O(43.94% vs 34.28%),高呼气末正压(13-20 cm H2O)使用减少73.43%。与临床医生相比,模型大幅参数调整(>1个分箱)增加:FiO2 72.53%、呼气末正压348.15%、呼吸频率299.21%、扫气流速96.68%、血流速度34.16%,总体重大调整增加120.37%(3105次 vs 1409次)。作者认为该模型展示了动态但安全意识强的调整,与临床模式一致,有潜力作为补充临床判断的决策支持工具。

要点

  • 在184例静脉-静脉ECMO成人患者数据上开发的离线强化学习模型rECMOmender,可对FiO2、呼气末正压、呼吸频率、扫气流速和血流速度五个参数生成稳定、可解释的建议。
  • 模型最常选择FiO2 40-50%(46.75% vs 临床医生45.65%),倾向于呼气末正压9-11 cm H2O(43.94% vs 34.28%),高呼气末正压(13-20 cm H2O)使用较临床医生减少73.43%。
  • 与临床医生相比,模型大幅参数调整(>1个分箱)分别增加:FiO2 72.53%、呼气末正压348.15%、呼吸频率299.21%、扫气流速96.68%、血流速度34.16%。
  • 模型总体重大调整次数较临床医生增加120.37%(3105次 vs 1409次),作者认为这体现了动态但安全意识强的调整,与临床模式一致。
  • 作者认为rECMOmender有潜力作为补充临床判断的决策支持工具,而非替代临床医生。

适用人群与场景

  • 一家三级医疗中心接受静脉-静脉ECMO的成人患者,共184例,数据来自电子健康记录。

研究设计与关键结果

  • 研究类型:回顾性研究;样本量:184例成人静脉-静脉ECMO患者;数据来源:一家三级医疗中心电子健康记录。
  • 模型开发:采用保守Q学习,具有生理学信息奖励结构,比较了离散与连续动作空间及两种奖励公式的多个模型变体。
  • 性能评估:使用拟合Q评估、动作分布比较以及与临床实践的一致性。
  • 模型最常选择FiO2 40-50%(46.75% vs 临床医生45.65%),倾向于呼气末正压9-11 cm H2O(43.94% vs 34.28%),高呼气末正压(13-20 cm H2O)使用较临床医生减少73.43%。
  • 与临床医生相比,模型大幅参数调整(>1个分箱)增加:FiO2 72.53%、呼气末正压348.15%、呼吸频率299.21%、扫气流速96.68%、血流速度34.16%。
  • 模型总体重大调整次数较临床医生增加120.37%(3105次 vs 1409次)。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为rECMOmender有潜力作为决策支持工具,补充临床医生判断,而非替代临床决策。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: Management of ventilator and venovenous extracorporeal membrane oxygenation (ECMO) settings in critically ill adults requires individualized decisions to balance oxygenation, ventilation, and complication risks. Existing approaches rely heavily on clinician experience, with limited decision support tools available.

HYPOTHESIS: An offline reinforcement learning agent trained on real-world venovenous ECMO clinical data can generate safe, interpretable, and clinically aligned recommendations for ECMO and ventilator management, including support for earlier and more efficient weaning.

METHODS AND MODELS: We conducted a retrospective study using electronic health record data from 184 adult patients who underwent venovenous ECMO at a tertiary care center. rECMOmender was developed using conservative Q-learning with a physiologically informed reward structure. Multiple model variants were compared across discrete and continuous action spaces and two reward formulations. Performance was assessed using fitted Q evaluation, comparison of action distributions, and alignment with clinician practice.

RESULTS: rECMOmender generated stable, interpretable recommendations across five key parameters: Fio2, positive end-expiratory pressure (PEEP), respiratory rate, sweep gas flow, and blood flow rate. It selected Fio2 values in the 40-50% range most frequently (46.75% vs. 45.65% for clinicians) and favored PEEP of 9-11 cm H2O (43.94% vs. 34.28%), while using high PEEP settings (13-20 cm H2O) 73.43% less often. Compared with clinicians, rECMOmender increased large parameter shifts (> 1 bin) by 72.53% for Fio2, 348.15% for PEEP, 299.21% for respiratory rate, 96.68% for sweep gas, and 34.16% for blood flow, resulting in an overall 120.37% increase in major adjustments (3105 vs. 1409).

INTERPRETATIONS AND CONCLUSIONS: rECMOmender demonstrated dynamic but safety conscious adjustments that aligned with clinical patterns, indicating potential as a decision support tool that complements clinician judgment.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Song J, Dave SB, Yang Y, et al. rECMOmender: Reinforcement Learning for Decision Support in Venovenous Extracorporeal Membrane Oxygenation Management. Crit Care Explor. 2026. PMID: 41649906. doi:10.1097/CCE.0000000000001369

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。